Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Disodium Methanediphosphonate
2. Methane Diphosphonate
3. Methylene Diphosphonate
4. Methylene Diphosphonate, (32)p-labeled
5. Methylene Diphosphonate, Disodium Salt
6. Methylene Diphosphonate, Tetrasodium Salt
7. Methylene Diphosphonate, Tetrasodium Salt, (32)p-labeled
8. Methylene Diphosphonate, Tin(4+) Salt, (113)sn-labeled
9. Methylene Diphosphonate, Trisodium Salt
10. Methylene Diphosphonic Acid
1. Medronic Acid
2. 1984-15-2
3. Phosphonic Acid, Methylenebis-
4. Phosphonomethylphosphonic Acid
5. Medronate
6. Methanediphosphonic Acid
7. Acido Medronico
8. Acide Medronique
9. Acidum Medronicum
10. Methylene Diphosphonic Acid
11. Methylenebis(phosphonic Acid)
12. Mdp-bracco
13. Methanediylbis(phosphonic Acid)
14. Methanebisphosphonic Acid
15. Methylene-1,1-bisphosphonic Acid
16. Einecs 217-851-0
17. Phosphonic Acid, Methylenedi-
18. 73os0qin3o
19. Mls000048571
20. Chembl180570
21. (phosphonomethyl)phosphonic Acid
22. Chebi:43945
23. Medronic Acid (usan)
24. Smr000060476
25. Medronic Acid [usan]
26. Mdn
27. Acide Medronique [inn-french]
28. Acido Medronico [inn-spanish]
29. Acidum Medronicum [inn-latin]
30. Unii-73os0qin3o
31. Medronic-acid
32. Medronic Acid [usan:inn:ban]
33. Methylene Diphsphonate
34. Methandiphosphonic Acid
35. Opera_id_703
36. Medronic Acid [ii]
37. Medronic Acid [mi]
38. Dsstox_cid_25696
39. Dsstox_rid_81068
40. Medronic Acid [inn]
41. Dsstox_gsid_45696
42. Schembl66716
43. Methylene Bis-phosphonic Acid
44. Mdp, Methanediphosphonic Acid
45. Bis(dihydroxyphosphoryl)methane
46. Phosphonomethyl-phosphonic Acid
47. Medronic Acid [mart.]
48. Medronic Acid [who-dd]
49. Dtxsid8045696
50. Mbkdynnuvrnnrf-uhfffaoysa-
51. Amy31948
52. Bcp20495
53. Methylenediphosphonic Acid, >=99%
54. Zinc8015016
55. Tox21_110974
56. Bdbm50162816
57. Mfcd00002139
58. Phosphonic Acid, P,p'-methylenebis-
59. Stl302043
60. Akos001031749
61. Db14078
62. Ncgc00037856-01
63. Ncgc00037856-02
64. Cas-1984-15-2
65. Methylene Diphosphonic Acid [vandf]
66. Db-009770
67. Hy-108309
68. Cs-0028208
69. Ft-0628882
70. M0843
71. D04887
72. Diethylenetriaminepentakis(methylphosphonic Acid)
73. T72027
74. A928713
75. Methylenediphosphonic Acidmethylenediphosphonic Acid
76. Q2823283
77. Medronic Acid, European Pharmacopoeia (ep) Reference Standard
78. Methylenediphosphonic Acid, For Molecular Studies & Mass Spectrometry
Molecular Weight | 176.00 g/mol |
---|---|
Molecular Formula | CH6O6P2 |
XLogP3 | -3.3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 175.96396190 g/mol |
Monoisotopic Mass | 175.96396190 g/mol |
Topological Polar Surface Area | 115 Ų |
Heavy Atom Count | 9 |
Formal Charge | 0 |
Complexity | 152 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Mdp-bracco |
Active Ingredient | Technetium tc-99m medronate kit |
Dosage Form | Injectable |
Route | Injection |
Strength | n/a |
Market Status | Prescription |
Company | Bracco |
2 of 2 | |
---|---|
Drug Name | Mdp-bracco |
Active Ingredient | Technetium tc-99m medronate kit |
Dosage Form | Injectable |
Route | Injection |
Strength | n/a |
Market Status | Prescription |
Company | Bracco |
Bone Density Conservation Agents
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
92
PharmaCompass offers a list of Methylene Diphosphonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylene Diphosphonate manufacturer or Methylene Diphosphonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylene Diphosphonate manufacturer or Methylene Diphosphonate supplier.
PharmaCompass also assists you with knowing the Methylene Diphosphonate API Price utilized in the formulation of products. Methylene Diphosphonate API Price is not always fixed or binding as the Methylene Diphosphonate Price is obtained through a variety of data sources. The Methylene Diphosphonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Methylene Diphosphonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylene Diphosphonate, including repackagers and relabelers. The FDA regulates Methylene Diphosphonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylene Diphosphonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Methylene Diphosphonate supplier is an individual or a company that provides Methylene Diphosphonate active pharmaceutical ingredient (API) or Methylene Diphosphonate finished formulations upon request. The Methylene Diphosphonate suppliers may include Methylene Diphosphonate API manufacturers, exporters, distributors and traders.
click here to find a list of Methylene Diphosphonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Methylene Diphosphonate DMF (Drug Master File) is a document detailing the whole manufacturing process of Methylene Diphosphonate active pharmaceutical ingredient (API) in detail. Different forms of Methylene Diphosphonate DMFs exist exist since differing nations have different regulations, such as Methylene Diphosphonate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Methylene Diphosphonate DMF submitted to regulatory agencies in the US is known as a USDMF. Methylene Diphosphonate USDMF includes data on Methylene Diphosphonate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Methylene Diphosphonate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Methylene Diphosphonate suppliers with USDMF on PharmaCompass.
Methylene Diphosphonate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methylene Diphosphonate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methylene Diphosphonate GMP manufacturer or Methylene Diphosphonate GMP API supplier for your needs.
A Methylene Diphosphonate CoA (Certificate of Analysis) is a formal document that attests to Methylene Diphosphonate's compliance with Methylene Diphosphonate specifications and serves as a tool for batch-level quality control.
Methylene Diphosphonate CoA mostly includes findings from lab analyses of a specific batch. For each Methylene Diphosphonate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methylene Diphosphonate may be tested according to a variety of international standards, such as European Pharmacopoeia (Methylene Diphosphonate EP), Methylene Diphosphonate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methylene Diphosphonate USP).